Literature DB >> 3884667

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.

M Modan, H Halkin, S Almog, A Lusky, A Eshkol, M Shefi, A Shitrit, Z Fuchs.   

Abstract

Hypertension and glucose intolerance, determined in a random population sample (n = 2,475), showed a highly significant (P less than 0.001) association from the mildest levels of both conditions, independent of the confounding effects of age, sex, obesity, and antihypertensive medications. Summary rate ratios for hypertension were 1.48 (1.18-1.87) in abnormal tolerance and 2.26 (1.69-2.84) in diabetes compared with normal tolerance. Altogether, 83.4% of the hypertensives were either glucose-intolerant or obese--both established insulin-resistant conditions. Fasting and post-load insulin levels in a representative subgroup (n = 1,241) were significantly elevated in hypertension independent of obesity, glucose intolerance, age, and antihypertensive medications. The mean increment in summed 1- and 2-h insulin levels (milliunits per liter) compared with nonobese normotensives with normal tolerance was 12 for hypertension alone, 47 for obesity alone, 52 for abnormal tolerance alone, and 124 when all three conditions were present. The prevalence of concentrations (milliequivalents per liter) of erythrocyte Na+ greater than or equal to 7.0, K+ less than 92.5, and plasma K+ greater than or equal to 4.5 in a subsample of 59 individuals with all combinations of abnormal tolerance obesity and hypertension was compared with those in 30 individuals free of these conditions. Altogether, 88.1% of the former vs. 40.0% of the latter group presented at least one of these three markers of internal cation imbalance (P less than 0.001). We conclude that insulin resistance and/or hyperinsulinemia (a) are present in the majority of hypertensives, (b) constitute a common pathophysiologic feature of obesity, glucose intolerance, and hypertension, possibly explaining their ubiquitous association, and (c) may be linked to the increased peripheral vascular resistance of hypertension, which is putatively related to elevated intracellular sodium concentration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884667      PMCID: PMC423608          DOI: 10.1172/JCI111776

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  67 in total

1.  Serum-insulin in essential hypertension and in peripheral vascular disease.

Authors:  T A Welborn; A Breckenridge; A H Rubinstein; C T Dollery; T R Fraser
Journal:  Lancet       Date:  1966-06-18       Impact factor: 79.321

2.  Dietary sodium and potassium intake and blood pressure.

Authors:  G A MacGregor
Journal:  Lancet       Date:  1983-04-02       Impact factor: 79.321

3.  The diabetic diet, dietary carbohydrate and differences in digestibility.

Authors:  D J Jenkins; R H Taylor; T M Wolever
Journal:  Diabetologia       Date:  1982-12       Impact factor: 10.122

Review 4.  The experimental evidence for weight-loss treatment of essential hypertension: a critical review.

Authors:  M F Hovell
Journal:  Am J Public Health       Date:  1982-04       Impact factor: 9.308

Review 5.  Type 2 (non-insulin-dependent) diabetes--an epidemiological overview.

Authors:  P Zimmet
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

6.  Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension.

Authors:  R J Jarrett; H Keen; M McCartney; J H Fuller; P J Hamilton; D D Reid; G Rose
Journal:  Int J Epidemiol       Date:  1978-03       Impact factor: 7.196

7.  Human essential hypertension: implications of animal studies.

Authors:  L Tobian
Journal:  Ann Intern Med       Date:  1983-05       Impact factor: 25.391

8.  Abnormal red blood cell ion transport and hypertension. The People's Gas Company study.

Authors:  M Trevisan; D Ostrow; R Cooper; K Liu; S Sparks; A Okonek; E Stevens; J Marquardt; J Stamler
Journal:  Hypertension       Date:  1983 May-Jun       Impact factor: 10.190

9.  Mechanisms of insulin resistance in aging.

Authors:  R I Fink; O G Kolterman; J Griffin; J M Olefsky
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

10.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

View more
  196 in total

Review 1.  "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease.

Authors:  I Wilcox; S G McNamara; F L Collins; R R Grunstein; C E Sullivan
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 2.  The epidemiology of atherosclerosis and its risk factors among Native Americans.

Authors:  James M Galloway
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

3.  Hyperinsulinaemia and blood pressure in patients with insulinoma.

Authors:  N Fujita; T Baba; T Tomiyama; T Kodama; N Kako
Journal:  BMJ       Date:  1992-05-02

Review 4.  Pathogenesis of hypertension in diabetes.

Authors:  Sameer N Stas; Fadi A El-Atat; James R Sowers
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

5.  Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance.

Authors:  R W Bergstrom; D L Leonetti; L L Newell-Morris; W P Shuman; P W Wahl; W Y Fujimoto
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

6.  Potassium and magnesium in essential hypertension.

Authors:  P S Patki; G S Gokhale; J Singh; D S Shrotri; B Patwardhan
Journal:  BMJ       Date:  1990-12-01

7.  Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.

Authors:  E A Anderson; R P Hoffman; T W Balon; C A Sinkey; A L Mark
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 8.  Hypertension.

Authors:  G W Ching; D G Beevers
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

Review 9.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 10.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.